First trimester screening for gestational diabetes mellitus by maternal factors and markers of inflammation

Metabolism ◽  
2016 ◽  
Vol 65 (3) ◽  
pp. 131-137 ◽  
Author(s):  
Argyro Syngelaki ◽  
Gerard H.A. Visser ◽  
Konstantinos Krithinakis ◽  
Alan Wright ◽  
Kypros H. Nicolaides
2017 ◽  
Vol 216 (1) ◽  
pp. S321
Author(s):  
Brittney Donovan ◽  
Rebecca Baer ◽  
Scott Oltman ◽  
Larry Rand ◽  
Laura Jelliffe-Pawlowski ◽  
...  

2012 ◽  
Vol 29 (2) ◽  
pp. 137-140 ◽  
Author(s):  
Sevsen Kulaksizoglu ◽  
Mustafa Kulaksizoglu ◽  
Ayse Gul Kebapcilar ◽  
Ayse Nur Torun ◽  
Emel Ozcimen ◽  
...  

Author(s):  
Ida Näslund Thagaard ◽  
Lone Krebs ◽  
Jens-Christian Holm ◽  
Theis Lange ◽  
Torben Larsen ◽  
...  

AbstractBackground:Gestational diabetes mellitus (GDM) is increasing partly due to the obesity epidemic. Adipocytokines have thus been suggested as first trimester screening markers for GDM. In this study we explore the associations between body mass index (BMI) and serum concentrations of adiponectin, leptin, and the adiponectin/leptin ratio. Furthermore, we investigate whether these markers can improve the ability to screen for GDM in the first trimester.Methods:A cohort study in which serum adiponectin and leptin were measured between gestational weeks 6+0 and 14+0 in 2590 pregnant women, categorized into normal weight, moderately obese, or severely obese.Results:Lower concentrations of adiponectin were associated with GDM in all BMI groups; the association was more pronounced in BMI<35 kg/mConclusions:Low adiponectin measured in the first trimester is associated with the development of GDM; higher BMI was associated with lower performance of adiponectin, though this was insignificant. Leptin had an inverse relationship with GDM in severely obese women and did not improve the ability to predict GDM.


Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 86-LB
Author(s):  
TIANGE SUN ◽  
FANHUA MENG ◽  
RUI ZHANG ◽  
ZHIYAN YU ◽  
SHUFEI ZANG ◽  
...  

2020 ◽  
Vol 17 (1) ◽  
Author(s):  
Chuyao Jin ◽  
Lizi Lin ◽  
Na Han ◽  
Zhiling Zhao ◽  
Zheng Liu ◽  
...  

Abstract Background To assess the association between plasma retinol-binding protein 4 (RBP4) levels both in the first trimester and second trimester and risk of gestational diabetes mellitus (GDM). Methods Plasma RBP4 levels and insulin were measured among 135 GDM cases and 135 controls nested within the Peking University Birth Cohort in Tongzhou. Multivariable linear regression analysis was conducted to assess the influence of RBP4 levels on insulin resistance. Conditional logistic regression models were used to compute the odds ratio (OR) and 95% confidence interval (CI) between RBP4 levels and risk of GDM. Results The GDM cases had significantly higher levels of RBP4 in the first trimester than controls (medians: 18.0 μg/L vs 14.4 μg/L; P < 0.05). Plasma RBP4 concentrations in the first and second trimester were associated with fasting insulin, homeostasis model assessment for insulin resistance (HOMA-IR), and the quantitative insulin sensitivity check index (QUICKI) in the second trimester (all P < 0.001). With adjustment for diet, physical activity, and other risk factors for GDM, the risk of GDM increased with every 1-log μg/L increment of RBP4 levels, and the OR (95% CI) was 3.12 (1.08–9.04) for RBP4 in the first trimester and 3.38 (1.03–11.08) for RBP4 in the second trimester. Conclusions Plasma RBP4 levels both in the first trimester and second trimester were dose-dependently associated with increased risk of GDM.


Placenta ◽  
2021 ◽  
Vol 112 ◽  
pp. e32-e33
Author(s):  
Daniela Mennickent ◽  
Andrés Rodríguez ◽  
Juan Araya ◽  
Enrique Guzmán-Gutiérrez

2016 ◽  
Vol 39 (5) ◽  
pp. 577-583 ◽  
Author(s):  
Hüsnü Alptekin ◽  
Ahmet Çizmecioğlu ◽  
Hatice Işık ◽  
Türkan Cengiz ◽  
Murat Yildiz ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document